Traditional Chinese medicinal composition for treating essence-blood deficiency type hepatorenal syndromes

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicinal composition for treating essence-blood deficiency type hepatorenal syndromes. The traditional Chinese medicinal composition comprises, by weight, 4-8 parts of Colla Corii Asini, 4-8 parts of Radix Crepis Rigescentis, 4-8 parts of black sesame, 4-8 parts of Radix Cynanchi Bungei, 4-8 parts of root of shrubbery rhodiola, 4-8 parts of Rubus Hirsutus, 4-8 parts of Gymnadenia Conopsea, 4-8 parts of Elatostema Myrtillus and 4-8 parts of glycyrrhiza. The traditional Chinese medicinal composition has the advantages that the effect of tonifying essence, enriching blood and nourishing liver and kidney is achieved through combination of the herbs; clinical symptoms and signs of patients can be relieved effectively, the levels of blood urea nitrogen, creatinine and urine protein can be reduced, glomerular filtration rate can be increased, and renal function can be improved; the levels of glutamic-pyruvic transaminase and glutamic oxalacetic transaminase can be reduced, and liver function can be improved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating hepatorenal syndrome of essence and blood deficiency type. Background technique [0002] Hepatorenal syndrome (HRS) refers to a functional renal failure in patients with severe liver diseases such as cirrhosis and severe viral hepatitis without clear primary renal disease. It was first proposed by Helwig in 1932. At that time, it was used to describe acute renal failure after biliary obstruction surgery. Later, it was used to refer to all diseases involving the liver and kidney at the same time. At present, it often refers to liver cirrhosis, fulminant hepatic failure, severe viral hepatitis, primary Functional renal failure secondary to severe liver disease such as primary or secondary liver cancer. There are no primary and specific organic lesions in the kidneys of patients with hepatorenal syndrome, and ther...

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of hepatorenal syndrome is not fully understood by Western medicine, and there is no effective treatment for it.